The information available and accessible below is disclosed in accordance with AIM Rule 26. This information was last updated on 7 July 2025.


Country of Incorporation and Main Country of Operation

Poolbeg Pharma Plc is incorporated and registered in England and Wales and its main country of operation is the UK.

Total Shares in Issue

697,200,000

Shareholdings

Significant Shareholders*Shares%
Cathal Friel41,219,7575.91%
Roaring Waters Capital40,000,0005.74%
Michael Kelly35,443,1325.08%
Allan Rankin27,016,0383.87%
*Except those exempt under DTR 5.1.5 regulation

Directors Shareholding Shares%
Cathal Friel41,219,7575.91%
Jeremy Skillington873,4970.13%
Ian O’Connell8,326,8391.19%
Brendan Buckley2,631,4740.38%

Shares Not in Public Hands

Pursuant to the AIM rules, and insofar as it is aware, at 7 July 2025, 7.61% of the Company’s securities were not in public hands. There are no shares held in treasury.

Securities Information

The Company is subject to the UK City Code on Takeovers and Mergers.

There are no restrictions on the transfer of ordinary shares.

The shares of the Company are traded on the AIM market operated by the London Stock Exchange.

Company Secretary

Beach Secretaries Limited

Company Registration Number

13279507

International Securities Identification Number (ISIN)

GB00BKPG7Z60

 Documents

Articles of AssociationDownload
Admission DocumentDownload

Annual Reports & Accounts

2024 Annual ReportDownload
View All

Get in touch with our investor relations team at

[email protected]

Poolbeg Pharma
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.